106 related articles for article (PubMed ID: 8189558)
1. Cell kinetics of renal cell carcinoma studied with in vivo iododeoxyuridine incorporation and flow cytometry.
Ljungberg B; Larsson P; Roos G; Stenling R; Wilson G
J Urol; 1994 Jun; 151(6):1509-13. PubMed ID: 8189558
[TBL] [Abstract][Full Text] [Related]
2. Proliferation of human renal cell carcinoma studied with in vivo iododeoxyuridine labelling and immunohistochemistry.
Larsson P; Roos G; Stenling R; Ljungberg B
Scand J Urol Nephrol; 1994 Jun; 28(2):135-40. PubMed ID: 7939463
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
Ljungberg B; Larsson P; Stenling R; Roos G
J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
Currin SM; Lee SE; Walther PJ
J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
9. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
[TBL] [Abstract][Full Text] [Related]
10. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
al-Abadi H; Nagel R
Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
[TBL] [Abstract][Full Text] [Related]
11. Localized renal cell carcinoma treated by radical nephrectomy. Influence of pathologic data and the importance of DNA ploidy pattern on disease outcome.
Raviv G; Leibovich I; Mor Y; Nass D; Medalia O; Goldwasser B; Nativ O
Cancer; 1993 Oct; 72(7):2207-12. PubMed ID: 8374878
[TBL] [Abstract][Full Text] [Related]
12. Cell proliferation in renal cell carcinoma--a comparative study of cell kinetic methods.
Larsson P; Roos G; Stenling R; Wilson GD; Ljungberg B
Urol Res; 1996; 24(5):291-5. PubMed ID: 8931294
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of DNA ploidy in small renal cell carcinoma.
Shalev M; Gdor Y; Leventis A; Radnay J; Shapiro H; Bernheim J; Nissenkorn I
Pathol Res Pract; 2001; 197(1):7-12. PubMed ID: 11209819
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
15. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Eskelinen M; Lipponen P; Nordling S
Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features.
Nakano E; Kondoh M; Okatani K; Seguchi T; Sugao H
Cancer; 1993 Aug; 72(4):1319-23. PubMed ID: 8339220
[TBL] [Abstract][Full Text] [Related]
17. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.
Ljungberg B; Mehle C; Stenling R; Roos G
Br J Cancer; 1996 Jul; 74(1):123-7. PubMed ID: 8679445
[TBL] [Abstract][Full Text] [Related]
19. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma.
Di Silverio F; Casale P; Colella D; Andrea L; Seccareccia F; Sciarra A
Cancer; 2000 Feb; 88(4):835-43. PubMed ID: 10679653
[TBL] [Abstract][Full Text] [Related]
20. DNA content, nuclear grading and early tumor progression in renal cell cancer: a prospective study on frozen specimens.
Cavazzana AO; Prayer-Galetti T; Sangiorgio A; Fassina AS; Panozzo M; Zucchetta P; Pagano F
Eur Urol; 1992; 22(4):311-5. PubMed ID: 1490509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
